TwinBeech Capital’s Cardlytics CDLX Stock Holding History

TwinBeech Capital’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,627	Closed	-$623K	–	719
2022 Q3	$623K	Buy	6,627 +2,275	+52%	+$324K	0.02%	497
2022 Q2	$971K	Buy	+4,352	New	+$1.46M	0.04%	327
2021 Q2	–	Sell	-320	Closed	-$351K	–	461
2021 Q1	$351K	Buy	+320	New	+$423K	0.05%	353

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

GEH

General Equity Holdings Brooklyn, New York $135M AUM 32.96% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

TwinBeech Capital's CDLX Position: Q4 2022 in Review

TwinBeech Capital sold out of Cardlytics (CDLX) in Q4 2022, closing a stake of 6,627 shares — an estimated $623K sold.

TwinBeech Capital first reported a position in CDLX in Q1 2021 and held it in 3 quarters. The position peaked at $971K in Q2 2022. 121 funds tracked by Wall St. Rank hold CDLX as of Q4 2022.

TwinBeech Capital reported no remaining Cardlytics position as of Q4 2022 after selling out during the quarter.
TwinBeech Capital sold 6,627 Cardlytics shares in Q4 2022, an estimated $623K.
TwinBeech Capital first reported a position in Cardlytics in Q1 2021 and held it in 3 quarters.
TwinBeech Capital's Cardlytics position peaked at $971K in Q2 2022.
121 funds tracked by Wall St. Rank held Cardlytics as of Q4 2022.

Based on TwinBeech Capital's 13F filing for Q4 2022, filed 14 Feb 2023.